The RNA Binding Domain of Jerky Consists of Tandemly Arranged Helix-Turn-Helix/Homeodomain-Like Motifs and Binds Specific Sets of mRNAs

REFERENCES

• Bandziulis, R. J., M. S. Swanson, and G. Dreyfuss. 1989. RNA-binding proteins as developmental regulators. Genes Dev. 3: 431–437.
   PubMed Web of Science ®Google Scholar
• Banerjee-Basu, S., and A. D. Baxevanis. 2001. Molecular evolution of the homeodomain family of transcription factors. Nucleic Acids Res. 29: 3258–3269.
   PubMed Web of Science ®Google Scholar
• Berkovic, S. F., M. L. Kennerson, R. A. Howell, I. E. Scheffer, P. A. Hwang, and G. A. Nicholson. 1994. Phenotypic expression of benign familial neonatal convulsions linked to chromosome 20. Arch. Neurol. 51: 1125–1128.
   PubMedGoogle Scholar
• Berkovic, S. F., A. McIntosh, R. A. Howell, A. Mitchell, L. J. Sheffield, and J. L. Hopper. 1996. Familial temporal lobe epilepsy: a common disorder identified in twins. Ann. Neurol. 40: 227–235.
   PubMed Web of Science ®Google Scholar
• Brown, V., P. Jin, S. Ceman, J. C. Darnell, W. T. O'Donnell, S. A. Tenenbaum, X. Jin, Y. Feng, K. D. Wilkinson, J. D. Keene, et al.. 2001. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107: 477–487.
   PubMed Web of Science ®Google Scholar
• Burz, D. S., R. Rivera-Pomar, H. Jackle, and S. D. Hanes. 1998. Cooperative DNA-binding by Bicoid provides a mechanism for threshold-dependent gene activation in the Drosophila embryo. EMBO J. 17: 5998–6009.
   PubMedGoogle Scholar
• Cendes, F., I. Lopes-Cendes, E. Andermann, and F. Andermann. 1998. Familial temporal lobe epilepsy: a clinically heterogeneous syndrome. Neurology 50: 554–557.
   PubMed Web of Science ®Google Scholar
• Chen, L., and M. Toth. 2001. Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 103: 1043–1050.
   PubMedGoogle Scholar
• Donovan, G. P., C. Harden, J. Gal, L. Ho, E. Sibille, R. Trifiletti, L. J. Gudas, and M. Toth. 1997. Sensitivity to jerky gene dosage underlies epileptic seizures in mice. J. Neurosci. 17: 4562–4569.
   PubMedGoogle Scholar
• Driever, W., and C. Nusslein-Volhard. 1989. The bicoid protein is a positive regulator of hunchback transcription in the early Drosophila embryo. Nature 337: 138–143.
   PubMed Web of Science ®Google Scholar
• Dubnau, J., and G. Struhl. 1996. RNA recognition and translational regulation by a homeodomain protein. Nature 379: 694–699.
   PubMed Web of Science ®Google Scholar
• Eberhart, D. E., H. E. Malter, Y. Feng, and S. T. Warren. 1996. The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum. Mol. Genet. 5: 1083–1091.
   PubMed Web of Science ®Google Scholar
• Gambardella, A., D. Messina, E. Le Piane, R. L. Oliveri, G. Annesi, M. Zappia, E. Andermann, A. Quattrone, and U. Aguglia. 2000. Familial temporal lobe epilepsy autosomal dominant inheritance in a large pedigree from southern Italy. Epilepsy Res. 38: 127–132.
   PubMed Web of Science ®Google Scholar
• Gao, Q., and R. Finkelstein. 1998. Targeting gene expression to the head: the Drosophila orthodenticle gene is a direct target of the Bicoid morphogen. Dev. Suppl. 125: 4185–4193.
   Google Scholar
• Guerrini, R., C. Dravet, A. R. Ferrari, A. Battaglia, M. G. Mattei, P. Salvadori, P. Genton, and P. Pfanner. 1993. The evolution of epilepsy in the most common genetic forms with mental retardation (Down's syndrome and the fragile X syndrome). Pediatr. Med. Chiragu 15(Suppl. 1): 19–22.
   PubMedGoogle Scholar
• Hayes, J. D., and R. C. Strange. 2000. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61: 154–166.
   PubMed Web of Science ®Google Scholar
• Hyslop, P. A., Z. Zhang, D. V. Pearson, and L. A. Phebus. 1995. Measurement of striatal H2O2 by microdialysis following global forebrain ischemia and reperfusion in the rat: correlation with the cytotoxic potential of H2O2 in vitro. Brain Res. 671: 181–186.
   PubMed Web of Science ®Google Scholar
• Ikeda, A., T. Kunieda, S. Miyamoto, H. Fukuyama, and H. Shibasaki. 2000. Autosomal dominant temporal lobe epilepsy in a Japanese family. J. Neurol. Sci. 176: 162–165.
   PubMedGoogle Scholar
• Iwahara, J., T. Kigawa, K. Kitagawa, H. Masumoto, T. Okazaki, and S. Yokoyama. 1998. A helix-turn-helix structure unit in human centromere protein B (CENP-B). EMBO J. 17: 827–837.
   PubMedGoogle Scholar
• Kenan, D. J., C. C. Query, and J. D. Keene. 1991. RNA recognition: towards identifying determinants of specificity. Trends Biochem. Sci. 16: 214–220.
   PubMedGoogle Scholar
• Khandjian, E. W., F. Corbin, S. Woerly, and F. Rousseau. 1996. The fragile X mental retardation protein is associated with ribosomes. Nat. Genet. 12: 91–93.
   PubMed Web of Science ®Google Scholar
• Kiledjian, M., and G. Dreyfuss. 1992. Primary structure and binding activity of the hnRNP U protein: binding RNA through RGG box. EMBO J. 11: 2655–2664.
   PubMed Web of Science ®Google Scholar
• Laggerbauer, B., D. Ostareck, E. M. Keidel, A. Ostareck-Lederer, and U. Fischer. 2001. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10: 329–338.
   PubMed Web of Science ®Google Scholar
• Lazinski, D., E. Grzadzielska, and A. Das. 1989. Sequence-specific recognition of RNA hairpins by bacteriophage antiterminators requires a conserved arginine-rich motif. Cell 59: 207–218.
   PubMed Web of Science ®Google Scholar
• Li, Z., Y. Zhang, L. Ku, K. D. Wilkinson, S. T. Warren, and Y. Feng. 2001. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res. 29: 2276–2283.
   PubMed Web of Science ®Google Scholar
• Liu, W., J. Seto, G. Donovan, and M. Toth. 2002. Jerky, a protein deficient in a mouse epilepsy model, is associated with translationally inactive mRNA in neurons. J. Neurosci. 22: 176–182.
   PubMedGoogle Scholar
• Matz, P. G., A. Lewen, and P. H. Chan. 2001. Neuronal, but not microglial, accumulation of extravasated serum proteins after intracerebral hemolysate exposure is accompanied by cytochrome c release and DNA fragmentation. J. Cereb. Blood Flow Metab. 21: 921–928.
   PubMed Web of Science ®Google Scholar
• Meyuhas, O., D. Avni, and S. Shama. 1996. Translational control of ribosomal protein mRNAs in eukaryotes, p. 363–388. In J. W. B. Hershey, M. B. Mathews, and N. Sonenberg, (ed.), Translational control. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Moore, T., S. Hecquet, A. McLellann, D. Ville, D. Grid, F. Picard, B. Moulard, P. Asherson, A. J. Makoff, D. McCormick, et al. 2001. Polymorphism analysis of JRK/JH8, the human homologue of mouse jerky, and description of a rare mutation in a case of CAE evolving to JME. Epilepsy Res. 46: 157–167.
   PubMedGoogle Scholar
• Morita-Fujimura, Y., M. Fujimura, M. Kawase, S. F. Chen, and P. H. Chan. 1999. Release of mitochondrial cytochrome c and DNA fragmentation after cold injury-induced brain trauma in mice: possible role in neuronal apoptosis. Neurosci. Lett. 267: 201–205.
   PubMed Web of Science ®Google Scholar
• Musumeci, S. A., P. Bosco, G. Calabrese, C. Bakker, G. B. De Sarro, M. Elia, R. Ferri, and B. A. Oostra. 2000. Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia 41: 19–23.
   PubMed Web of Science ®Google Scholar
• Musumeci, S. A., R. J. Hagerman, R. Ferri, P. Bosco, B. Dalla Bernardina, C. A. Tassinari, G. B. De Sarro, and M. Elia. 1999. Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia 40: 1092–1099.
   PubMedGoogle Scholar
• Niessing, D., W. Driever, F. Sprenger, H. Taubert, H. Jackle, and R. Rivera-Pomar. 2000. Homeodomain position 54 specifies transcriptional versus translational control by Bicoid. Mol. Cell 5: 395–401.
   PubMedGoogle Scholar
• Olanow, C. W. 1993. A radical hypothesis for neurodegeneration. Trends Neurosci. 16: 439–444.
   PubMed Web of Science ®Google Scholar
• Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609–619.
   PubMed Web of Science ®Google Scholar
• Picard, F., S. Baulac, P. Kahane, E. Hirsch, R. Sebastianelli, P. Thomas, F. Vigevano, P. Genton, R. Guerrini, C. A. Gericke, et al. 2000. Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families. Brain 123: 1247–1262.
   PubMedGoogle Scholar
• Poza, J. J., A. Saenz, A. Martinez-Gil, N. Cheron, A. M. Cobo, M. Urtasun, J. F. Marti-Masso, D. Grid, J. S. Beckmann, J. F. Prud'homme, and A. Lopez de Munain. 1999. Autosomal dominant lateral temporal epilepsy: clinical and genetic study of a large Basque pedigree linked to chromosome 10q. Ann. Neurol. 45: 182–188.
   PubMed Web of Science ®Google Scholar
• Qiu, J., M. J. Whalen, P. Lowenstein, G. Fiskum, B. Fahy, R. Darwish, B. Aarabi, J. Yuan, and M. A. Moskowitz. 2002. Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans. J. Neurosci. 22: 3504–3511.
   PubMedGoogle Scholar
• Rabilloud, T., M. Heller, F. Gasnier, S. Luche, C. Rey, R. Aebersold, M. Benahmed, P. Louisot, and J. Lunardi. 2002. Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J. Biol. Chem. 277: 19396–19401.
   PubMed Web of Science ®Google Scholar
• Rivera-Pomar, R., D. Niessing, U. Schmidt-Ott, W. J. Gehring, and H. Jackle. 1996. RNA binding and translational suppression by bicoid. Nature 379: 746–749.
   PubMed Web of Science ®Google Scholar
• Rosch, P., and D. Willbold. 1996. Is EIAV Tat protein a homeodomain? Science 272: 1672.
   PubMedGoogle Scholar
• Saenz, A., J. Galan, C. Caloustian, F. Lorenzo, C. Marquez, N. Rodriguez, M. D. Jimenez, J. J. Poza, A. M. Cobo, D. Grid, et al. 1999. Autosomal dominant nocturnal frontal lobe epilepsy in a Spanish family with a Ser252Phe mutation in the CHRNA4 gene. Arch. Neurol. 56: 1004–1009.
   PubMedGoogle Scholar
• Samali, A., and S. Orrenius. 1998. Heat shock proteins: regulators of stress response and apoptosis. Cell Stress Chaperones 3: 228–236.
   PubMed Web of Science ®Google Scholar
• Schaeffer, C., B. Bardoni, J. L. Mandel, B. Ehresmann, C. Ehresmann, and H. Moine. 2001. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J. 20: 4803–4813.
   PubMed Web of Science ®Google Scholar
• Simonian, N. A., and J. T. Coyle. 1996. Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36: 83–106.
   PubMed Web of Science ®Google Scholar
• Siomi, H., M. C. Siomi, R. L. Nussbaum, and G. Dreyfuss. 1993. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74: 291–298.
   PubMed Web of Science ®Google Scholar
• Slee, E. A., M. T. Harte, R. M. Kluck, B. B. Wolf, C. A. Casiano, D. D. Newmeyer, H. G. Wang, J. C. Reed, D. W. Nicholson, E. S. Alnemri, et al. 1999. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144: 281–292.
   PubMed Web of Science ®Google Scholar
• Struhl, G., K. Struhl, and P. M. Macdonald. 1989. The gradient morphogen bicoid is a concentration-dependent transcriptional activator. Cell 57: 1259–1273.
   PubMed Web of Science ®Google Scholar
• Sugawara, T., M. Fujimura, Y. Morita-Fujimura, M. Kawase, and P. H. Chan. 1999. Mitochondrial release of cytochrome c corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral ischemia. J. Neurosci. 19: RC39.
   PubMedGoogle Scholar
• Swanson, M. S., T. Y. Nakagawa, K. LeVan, and G. Dreyfuss. 1987. Primary structure of human nuclear ribonucleoprotein particle C proteins: conservation of sequence and domain structures in heterogeneous nuclear RNA, mRNA, and pre-rRNA-binding proteins. Mol. Cell. Biol. 7: 1731–1739.
   PubMed Web of Science ®Google Scholar
• Tanaka, Y., O. Nureki, H. Kurumizaka, S. Fukai, S. Kawaguchi, M. Ikuta, J. Iwahara, T. Okazaki, and S. Yokoyama. 2001. Crystal structure of the CENP-B protein-DNA complex: the DNA-binding domains of CENP-B induce kinks in the CENP-B box DNA. EMBO J. 20: 6612–6618.
   PubMedGoogle Scholar
• Tenenbaum, S. A., C. C. Carson, P. J. Lager, J. D. Keene. 2000. Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc. Natl. Acad. Sci. USA 97: 14085–14090.
   PubMed Web of Science ®Google Scholar
• Toth, M. 2001. RNA binding proteins and epilepsy. Gene Function Dis. 2: 95–98.
   Google Scholar
• Toth, M., J. Grimsby, G. Buzsaki, and G. P. Donovan. 1995. Epileptic seizures caused by inactivation of a novel gene, jerky, related to centromere binding protein-B in transgenic mice. Nat. Genet. 11: 71–75.
   PubMedGoogle Scholar
• Wisniewski, K. E., J. H. French, S. Fernando, W. T. Brown, E. C. Jenkins, E. Friedman, A. L. Hill, and C. M. Miezejeski. 1985. Fragile X syndrome: associated neurological abnormalities and developmental disabilities. Ann. Neurol. 18: 665–669.
   PubMed Web of Science ®Google Scholar
• Wisniewski, K. E., S. M. Segan, C. M. Miezejeski, E. A. Sersen, and R. D. Rudelli. 1991. The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. Am. J. Med. Genet. 38: 476–480.
   PubMedGoogle Scholar